RxDoctor Payments Data

Dimple Varughese, PA

Physician Assistant · Dallas, TXNPI 1609938372

Payments from drug & device makers

$474in general payments, 2019–2025

Across 27 payments — averaging $17.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$176
  • Novo Nordisk$89
  • AstraZeneca$41
  • Genentech USA, Inc.$33
  • Biohaven Pharmaceutical Holding Company Ltd.$19
  • Pfizer$17
  • plus $100 from 7 others

What the payments were for

  • Food & beverage$474100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$474 in reported general payments places this provider in the 50th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$38,784
Medicare patients
337
Services billed
850

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PaxlovidNirmatrelvir/Ritonavir24$1,429
Albuterol Sulfate HfaAlbuterol Sulfate39$924
Fluticasone Propionate53$727
Omeprazole20$555
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav61$519
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst43$517
Montelukast Sodium36$449
Gabapentin23$447
ClopidogrelClopidogrel Bisulfate20$429
Pantoprazole Sodium18$422
Ipratropium Bromide15$378
Cyclobenzaprine Hcl27$309
Doxycycline Monohydrate28$300
Cefdinir16$299
Oseltamivir Phosphate14$242

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPaxlovid$17$1,42924 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →